Evaluation of intranasal nafamostat or camostat for SARS-CoV-2 chemoprophylaxis in Syrian golden hamsters
Neary, M.; Box, H.; Sharp, J.; Tatham, L.; Curley, P.; Herriott, J.; Kijak, E.; Arshad, U.; Hobson, J. J.; Rajoli, R. K.; Pertinez, H.; Valentijn, A.; Dhaliwal, K.; McCaughan, F.; Rannard, S. P.; Kipar, A.; Stewart, J. P.; Owen, A.
Show abstract
Successful development of a chemoprophylaxis against SARS-CoV-2 could provide a tool for infection prevention implementable alongside vaccination programmes. Camostat and nafamostat are serine protease inhibitors that inhibit SARS-CoV-2 viral entry in vitro but have not been characterised for chemoprophylaxis in animal models. Clinically, nafamostat is limited to intravenous delivery and while camostat is orally available, both drugs have extremely short plasma half-lives. This study sought to determine whether intranasal dosing at 5 mg/kg twice daily was able to prevent airborne transmission of SARS-CoV-2 from infected to uninfected Syrian golden hamsters. SARS-CoV-2 viral RNA was above the limits of quantification in both saline- and camostat-treated hamsters 5 days after cohabitation with a SARS-CoV-2 inoculated hamster. However, intranasal nafamostat-treated hamsters remained RNA negative for the full 7 days of cohabitation. Changes in body weight over the course of the experiment were supportive of a lack of clinical symptomology in nafamostat-treated but not saline- or camostat-treated animals. These data are strongly supportive of the utility of intranasally delivered nafamostat for prevention of SARS-CoV-2 infection and further studies are underway to confirm absence of pulmonary infection and pathological changes.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Infectious potential and circulation of SARS-CoV-2 in wild rats 93%
- Presence and Stability of SARS-CoV-2 on Environmental Currency and Money Cards 93%
- From “don, doff, and discard” to “don, doff, and decontaminate” – determination of filtering facepiece respirator and surgical mask integrity and inactivation of a SARS-CoV-2 surrogate and a small non-enveloped virus following multiple-cycles of vaporised hydrogen peroxide, ultraviolet germicidal irradiation, and dry heat decontamination 93%
Similar papers in this journal
- Protective immunity of the primary SARS-CoV-2 infection reduces disease severity post re-infection with Delta variants in Syrian hamsters 95%
- ZRC3308 monoclonal antibody cocktail shows protective efficacy in Syrian hamsters against SARS-CoV-2 infection 94%
- SARS-CoV-2 Delta variant pathogenesis and host response in Syrian hamsters 94%
Similar papers in this journal
- A Whole Virion Vaccine for COVID-19 Produced Via a Novel Inactivation Method: Results from Animal Challenge Model Studies 95%
- Development of a Well-Characterized Cynomolgus Macaque Model of Sudan Virus Disease for Support of Product Development 95%
- Immunogenicity and Efficacy of TNX-1800, A Live Virus Recombinant Poxvirus Vaccine Candidate, Against SARS-CoV-2 Challenge in Nonhuman Primates 94%
Similar papers in this journal
- Compartmentalized SARS-CoV-2 replication in upper versus lower respiratory tract after intranasal inoculation or aerosol exposure 95%
- Nipah virus Bangladesh infection elicits organ-specific innate and inflammatory responses in the marmoset model 93%
- Risk of SARS-CoV-2 transmission by fomites: a clinical observational study in highly infectious COVID-19 patients 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.